Index of reports
> Life Threatening Events (43)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Torsemide life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 43 Next >>
Possible Torsemide side effects in 75 year old male
Reported by a physician from Switzerland on 2012-08-27
Patient: 75 year old male, weighing 88.0 kg (193.6 pounds)
Reactions: Myoclonus, Drug Level Increased, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Lasix
Administration route: Oral
Start date: 2012-03-13
End date: 2012-04-07
Vancocin Hydrochloride
Start date: 2012-04-07
End date: 2012-04-21
Lasix
Administration route: Oral
Start date: 2012-04-09
End date: 2012-04-16
Tramadol Hydrochloride
Start date: 2012-03-13
End date: 2012-03-14
Duragesic-100
Start date: 2012-04-11
End date: 2012-04-19
Citalopram Hydrobromide
Administration route: Oral
Start date: 2012-04-03
Cefepime Hydrochloride
Start date: 2012-04-07
End date: 2012-04-21
Lasilacton
Administration route: Oral
Start date: 2012-04-07
Torsemide
Administration route: Oral
Start date: 2012-04-17
Morphine Hydrochloride
Dosage: dose 2%
Start date: 2012-03-13
Other drugs received by patient: Cozaar; Marcumar; Novalgin; Allopurinol; Perenterol; Motilium; Fragmin; Pipamperone; Nitroderm; Lyrica; Acetaminophen; Navoban; Pantoprazole; Droperidol; Konakion; Fragmin; Ondansetron; Levothyroxine Sodium; Metoprolol Tartrate; Loperamide HCL; Moviprep; Folvite
Possible Torsemide side effects in 61 year old female
Reported by a physician from Germany on 2012-08-27
Patient: 61 year old female, weighing 70.0 kg (154.0 pounds)
Reactions: Hepatotoxicity, Presyncope
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Clopidogrel Bisulfate
Dosage: 75 milligram
Indication: Prophylaxis
Dexamethasone
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-02-24
End date: 2011-03-17
Allopurinol
Dosage: 300 milligram
Dexamethasone
Dosage: 40 milligram
Administration route: Oral
Start date: 2011-03-10
End date: 2011-03-17
Revlimid
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-02-24
End date: 2011-03-16
Pantoprazole
Dosage: 40 milligram
Acyclovir
Dosage: 400 milligram
Torsemide
Dosage: 10 milligram
Indication: Hypertension
Enalapril Maleate
Dosage: 10 milligram
Other drugs received by patient: Amitriptyline HCL; Trimethoprim + Sulfamethoxazole; Valoron; Amitriptyline Hydrochloride; Lyrica; Enoxaparin Sodium; Moviprep; Soventol Gel; Folsan; Morphine; Morphine; Valoron; Cotrim DS
Possible Torsemide side effects in 75 year old male
Reported by a health professional (non-physician/pharmacist) from Switzerland on 2012-08-20
Patient: 75 year old male, weighing 88.0 kg (193.6 pounds)
Reactions: Myoclonus, Drug Level Increased, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Lasix
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-04-09
End date: 2012-04-16
Morphine
Indication: Product Used FOR Unknown Indication
Start date: 2012-03-13
Vancocin Hydrochloride
Indication: Intervertebral Discitis
Start date: 2012-04-07
End date: 2012-04-21
Lasix
Administration route: Oral
Start date: 2012-03-13
End date: 2012-04-07
Duragesic-100
Indication: Product Used FOR Unknown Indication
Start date: 2012-04-11
End date: 2012-04-19
Citalopram Hydrobromide
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-04-03
Tramadol Hydrochloride
Indication: Product Used FOR Unknown Indication
Start date: 2012-03-13
End date: 2012-03-14
Lasilactone
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-04-07
Torsemide
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-04-17
Cefepime
Indication: Intervertebral Discitis
Start date: 2012-04-07
End date: 2012-04-21
Other drugs received by patient: Metoprolol Tartrate; Moviprep; Dalteparin Sodium; Dalteparin Sodium; Novalgin; Folvite; Marcumar; Acetaminophen; Lyrica; Navoban; Cozaar; Imodium; Perenterol; Ondansetron; Dipiperon; Nitroderm; Motilium; Levothyroxine Sodium; Allopurinol; Konakion; Droperidol; Pantoprazole
Possible Torsemide side effects in 87 year old male
Reported by a physician from United States on 2012-08-08
Patient: 87 year old male, weighing 84.8 kg (186.6 pounds)
Reactions: Renal Failure
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Spironolactone
Indication: Cardiac Failure Congestive
Start date: 2009-01-21
Zaroxolyn
Indication: Cardiac Failure Congestive
Start date: 2012-01-29
Torsemide
Indication: Cardiac Failure Congestive
Start date: 2010-08-25
Tafamidis Meglumine
Administration route: Oral
Indication: Amyloidosis
Start date: 2008-12-05
Other drugs received by patient: Ambien; Synthroid; Coumadin; Lipitor; Allopurinol; Colchicine; Colchicine
Possible Torsemide side effects in male
Reported by a physician from Germany on 2012-07-31
Patient: male
Reactions: Loss of Consciousness
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Xarelto
Dosage: 10 mg, hs
Administration route: Oral
Indication: Knee Arthroplasty
Arcoxia
Administration route: Oral
Indication: Pain
Bisoprolol Fumarate
Administration route: Oral
Indication: Hypertension
Opium Alkaloids and Derivatives
Indication: Product Used FOR Unknown Indication
Ramipril
Administration route: Oral
Indication: Hypertension
Amitriptyline HCL
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Torsemide
Administration route: Oral
Indication: Diuretic Therapy
Amlodipine
Administration route: Oral
Indication: Hypertension
Voltaren
Administration route: Oral
Indication: Pain
Pantoprazole
Administration route: Oral
Indication: Gastric Disorder
Targin
Indication: Pain
Alfuzosin
Administration route: Oral
Indication: Prostatic Disorder
Possible Torsemide side effects in 87 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-31
Patient: 87 year old male, weighing 84.8 kg (186.6 pounds)
Reactions: Renal Failure, Cardiac Failure Congestive
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Spironolactone
Dosage: 12.5 mg (12.5 mg,1 in 1 d),oral
Administration route: Oral
Indication: Cardiac Failure Congestive
Start date: 2009-01-21
Torsemide
Dosage: 200 mg (100 mg,2 in 1 d),oral
Administration route: Oral
Indication: Cardiac Failure Congestive
Start date: 2010-08-25
Tafamidis Meglumine
Dosage: 20 mg (20 mg, 1 in 1 d),oral
Administration route: Oral
Indication: Amyloidosis
Start date: 2008-12-05
Zaroxolyn
Dosage: as needed (2.5 mg),oral
Administration route: Oral
Indication: Cardiac Failure Congestive
Start date: 2010-01-29
Other drugs received by patient: Ambien; Synthroid; Colchicine; Lipitor; Allopurinol; Coumadin
Possible Torsemide side effects in 87 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-23
Patient: 87 year old male, weighing 84.8 kg (186.6 pounds)
Reactions: Renal Failure, Peritoneal Dialysis, Condition Aggravated, Cardiac Failure Congestive
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Zaroxolyn
Indication: Cardiac Failure Congestive
Start date: 2012-01-29
Spironolactone
Indication: Cardiac Failure Congestive
Start date: 2009-01-21
Torsemide
Indication: Cardiac Failure Congestive
Start date: 2010-08-25
Tafamidis Meglumine
Dosage: 20mg (20 mg, 1 in 1 d),oral
Administration route: Oral
Indication: Amyloidosis
Start date: 2008-12-05
Other drugs received by patient: Ambien; Warfarin Sodium; Colchicine (Colchidine); Allopurinol; Synthroid; Lipitor
Possible Torsemide side effects in 46 year old female
Reported by a physician from United States on 2012-06-29
Patient: 46 year old female, weighing 180.0 kg (396.0 pounds)
Reactions: Diarrhoea, Adverse Drug Reaction, Anaphylactic Shock, Dermatitis Exfoliative
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Savella
Administration route: Oral
Indication: Fibromyalgia
Start date: 2011-09-07
End date: 2011-09-07
Savella
Administration route: Oral
Start date: 2011-09-08
End date: 2011-09-09
Savella
Administration route: Oral
Start date: 2011-09-10
End date: 2011-09-12
Prilosec
Administration route: Oral
Start date: 2011-06-01
Torsemide
Start date: 2011-07-13
Crestor
Administration route: Oral
Start date: 2011-06-01
Ibuprofen
Start date: 2011-06-01
Lovaza
Administration route: Oral
Start date: 2011-09-07
Other drugs received by patient: Allopurinol; Propranolol; Amitriptyline HCL; Amoxicillin; Potassium Acetate; Metformin HCL; Multi-Vitamin; Cranberry; Synthroid; Lisinopril; Oxybutynin; Vicodin; Adipex-P; Glimepiride; Warfarin Sodium; Vitamin D; Cinnamon; Fenofibrate; Wellbutrin
Possible Torsemide side effects in male
Reported by a physician from Germany on 2012-06-06
Patient: male
Reactions: Loss of Consciousness
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Pantoprazole
Administration route: Oral
Indication: Gastric Disorder
Alfuzosin HCL
Administration route: Oral
Indication: Prostatic Disorder
Amitriptyline HCL
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Opium Alkaloids and Derivatives
Indication: Ill-Defined Disorder
Opium / Naloxone TAB
Indication: Pain
Bisoprolol Fumarate
Administration route: Oral
Indication: Hypertension
Voltaren
Administration route: Oral
Indication: Pain
Arcoxia
Administration route: Oral
Indication: Pain
Xarelto
Administration route: Oral
Indication: Knee Arthroplasty
Torsemide
Administration route: Oral
Indication: Diuretic Therapy
Amlodipine
Administration route: Oral
Indication: Hypertension
Ramipril
Administration route: Oral
Indication: Hypertension
Possible Torsemide side effects in female
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-06-04
Patient: female
Reactions: International Normalised Ratio Increased
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Zofran
Indication: Vomiting
Zofran
Dosage: 12 mg
Indication: Nausea
Start date: 2012-02-15
End date: 2012-03-04
Sintrom
Dosage: 3 mg
Administration route: Oral
Indication: Atrial Fibrillation
End date: 2012-02-20
Citalopram
Dosage: 10 mg
Administration route: Oral
Indication: Depression
Torsemide
Dosage: 10 mg
Administration route: Oral
Other drugs received by patient: Laxoberon; Morphine; Digoxin; Vitamin D3 + Calcium TAB 500 MG; Floxapen; Digoxin; Lorazepam; Zolpidem
Possible Torsemide side effects in female
Reported by a physician from Japan on 2012-05-25
Patient: female, weighing 50.0 kg (110.0 pounds)
Reactions: Activated Partial Thromboplastin Time Prolonged, Rectal Haemorrhage, International Normalised Ratio Increased, Rectal Ulcer, Blood Creatinine Increased, Melaena
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Trichlormethiazide
Dosage: 1 mg
Administration route: Oral
Start date: 2012-03-02
End date: 2012-04-18
Pradaxa
Dosage: 220 mg
Administration route: Oral
Indication: Atrial Fibrillation
Start date: 2012-03-30
End date: 2012-04-18
Torsemide
Dosage: 4 mg
Administration route: Oral
Start date: 2012-03-29
End date: 2012-04-18
Etodolac
Dosage: 400 mg
Administration route: Oral
Start date: 2012-03-07
End date: 2012-04-18
Lasix
Dosage: 4 mg
Administration route: Oral
Start date: 2012-03-02
End date: 2012-04-18
Other drugs received by patient: Progogue D; Magnesium Oxide; Nexium; Depas; Rozerem; Rivastach; Norvasc
Possible Torsemide side effects in male
Reported by a physician from Germany on 2012-05-25
Patient: male
Reactions: Loss of Consciousness
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Xarelto
Administration route: Oral
Indication: Knee Arthroplasty
Voltaren
Administration route: Oral
Indication: Pain
Alfuzosin HCL
Administration route: Oral
Indication: Prostatic Disorder
Amitriptyline HCL
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Opium / Naloxone TAB
Indication: Pain
Torsemide
Administration route: Oral
Indication: Diuretic Therapy
Amlodipine Besylate
Administration route: Oral
Indication: Hypertension
Pantoprazole
Administration route: Oral
Indication: Gastric Disorder
Arcoxia
Administration route: Oral
Indication: Pain
Bisoprolol Fumarate
Administration route: Oral
Indication: Hypertension
Ramipril
Administration route: Oral
Indication: Hypertension
Possible Torsemide side effects in female
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-05-21
Patient: female
Reactions: International Normalised Ratio Increased
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Sintrom
Dosage: 3 mg
Administration route: Oral
Indication: Atrial Fibrillation
End date: 2012-02-20
Zofran
Dosage: 96 mg
Indication: Nausea
Start date: 2012-02-15
End date: 2012-03-04
Torsemide
Dosage: 10 mg
Administration route: Oral
Sintrom
Indication: Atrial Flutter
Zofran
Indication: Vomiting
Citalopram Hydrobromide
Dosage: 10 mg
Administration route: Oral
Indication: Depression
Other drugs received by patient: Lorazepam; Zolpidem; Vitamin D3 + Calcium TAB 500 MG; Floxapen; Digoxin; Morphine; Laxoberon; Digoxin
Possible Torsemide side effects in 83 year old female
Reported by a health professional (non-physician/pharmacist) from Switzerland on 2012-05-16
Patient: 83 year old female
Reactions: Vomiting, International Normalised Ratio Increased, Antibiotic Resistant Staphylococcus Test Positive, Constipation, Spondylitis, Anxiety, Sleep Disorder, Bacteraemia, Gastroenteritis Viral
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Sintrom
Dosage: see image
Administration route: Oral
Indication: Atrial Flutter
End date: 2012-02-20
Sintrom
Dosage: see image
Administration route: Oral
Indication: Atrial Fibrillation
End date: 2012-02-20
Citalopram Hydrobromide
Dosage: prior taking 5 mg at home (10 mg,1 in 1 d),oral
Administration route: Oral
Indication: Depression
Zofran
Dosage: 12 mg (4 mg,1 in 8 hr),intravenous drip
Indication: Vomiting
Start date: 2012-02-15
End date: 2012-03-04
Zofran
Dosage: 12 mg (4 mg,1 in 8 hr),intravenous drip
Indication: Nausea
Start date: 2012-02-15
End date: 2012-03-04
Torsemide
Dosage: 10 mg (10 mg,1 in 1 d),oral
Administration route: Oral
Other drugs received by patient: Zolpidem; Floxapen (Flucloxacillin); Laxoberon (Sodium Picosulfate); Morphine HCL (Morphine Hydrochloride); Digoxin; Lorazepam; Calcimagon D3 (Colecalciferol, Calcium Carbonate)
Possible Torsemide side effects in 84 year old female
Reported by a health professional (non-physician/pharmacist) from Switzerland on 2012-05-16
Patient: 84 year old female
Reactions: International Normalised Ratio Increased, Drug Interaction
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Citalopram Hydrobromide
Administration route: Oral
Indication: Depression
Zofran
Indication: Nausea
Start date: 2012-02-15
End date: 2012-03-04
Zofran
Indication: Vomiting
Torsemide
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Sintrom
Administration route: Oral
Indication: Atrial Fibrillation
Start date: 2012-02-16
End date: 2012-02-19
Other drugs received by patient: Temesta; Digoxin; Zolpidem; Laxoberon; Morphine; Colecalciferol; Floxapen
Possible Torsemide side effects in female
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-05-14
Patient: female
Reactions: International Normalised Ratio Increased
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Citalopram Hydrobromide
Dosage: 10 mg
Administration route: Oral
Indication: Depression
Sintrom
Dosage: 3 mg
Administration route: Oral
Indication: Atrial Fibrillation
End date: 2012-02-20
Zofran
Dosage: 96 mg
Indication: Nausea
Start date: 2012-02-15
End date: 2012-03-04
Zofran
Indication: Vomiting
Torsemide
Dosage: 10 mg
Administration route: Oral
Sintrom
Indication: Atrial Flutter
Other drugs received by patient: Floxapen; Digoxin; Temesta; Zolpidem; Digoxin; Morphine; Vitamin D3 + Calcium TAB 500 MG; Laxoberon
Possible Torsemide side effects in 83 year old female
Reported by a health professional (non-physician/pharmacist) from Switzerland on 2012-05-08
Patient: 83 year old female
Reactions: Vomiting, Nausea, Bacteraemia, Staphylococcal Infection, International Normalised Ratio Increased, Gastroenteritis Viral, Spondylitis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Zofran
Indication: Vomiting
Citalopram Hydrobromide
Dosage: 10 mg, daily dose, long term
Administration route: Oral
Zofran
Dosage: 4 mg, per 8 hours
Indication: Nausea
Start date: 2012-02-15
End date: 2012-03-04
Torsemide
Dosage: 10 mg, daily dose, long term
Administration route: Oral
Sintrom
Dosage: 3 mg, daily
Administration route: Oral
Indication: Atrial Fibrillation
End date: 2012-02-20
Other drugs received by patient: Floxapen; Digoxin; Calcimagon-D3; Morphin HCL; Zolpidem; Laxoberon; Digoxin
Possible Torsemide side effects in 83 year old female
Reported by a physician from Switzerland on 2012-05-07
Patient: 83 year old female
Reactions: International Normalised Ratio Increased
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Citalopram Hydrobromide
Dosage: 10mg per day
Administration route: Oral
Indication: Depression
Sintrom
Dosage: 3mg per day
Administration route: Oral
Indication: Arrhythmia Supraventricular
End date: 2012-02-20
Torsemide
Dosage: 10mg per day
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Zofran
Dosage: 4mg three times per day
Indication: Nausea
Start date: 2012-02-15
End date: 2012-03-04
Other drugs received by patient: Digoxin; Zolpidem; Floxapen; Morphine; Laxoberon; Lorazepam; Calcimagon-D3
Possible Torsemide side effects in 69 year old male
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-04-23
Patient: 69 year old male
Reactions: Circulatory Collapse, Drug Interaction
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Torsemide
Dosage: 10 mg, unk
Administration route: Oral
Indication: Cardiac Failure
Start date: 2006-01-01
End date: 2008-07-14
Xipamide
Dosage: 40 mg, 1x/day
Administration route: Oral
Indication: Cardiac Failure
Start date: 2008-06-24
End date: 2008-07-09
Other drugs received by patient possibly interacting with the suspect drug: Ramipril
Dosage: 2.5 mg, 2x/day
Administration route: Oral
Indication: Hypertension
Start date: 2007-01-01
End date: 2008-07-14
Bisobloc
Dosage: 2.5 mg, 1x/day
Administration route: Oral
Indication: Angina Pectoris
Start date: 2003-01-01
Ramipril
Dosage: unk
Start date: 2008-07-23
Other drugs received by patient: Insuman Comb 25; Clopidogrel Bisulfate; Acetylsalicylic Acid; Simvastatin
Possible Torsemide side effects in 69 year old male
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-04-20
Patient: 69 year old male
Reactions: Drug Interaction, Circulatory Collapse
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Xipamide
Dosage: 40 mg, 1x/day
Administration route: Oral
Indication: Cardiac Failure
Start date: 2008-06-24
End date: 2008-07-09
Torsemide
Dosage: 10 mg, unk
Administration route: Oral
Indication: Cardiac Failure
Start date: 2006-01-01
End date: 2008-07-14
Other drugs received by patient possibly interacting with the suspect drug: Ramipril
Dosage: 2.5 mg, 2x/day
Administration route: Oral
Indication: Hypertension
Start date: 2007-01-01
End date: 2008-07-14
Bisoprolol Fumarate
Dosage: 2.5 mg, 1x/day
Administration route: Oral
Indication: Angina Pectoris
Start date: 2003-01-01
Ramipril
Dosage: unk
Other drugs received by patient: Acetylsalicylic Acid; Simvastatin; Clopidogrel Bisulfate; Insuman Comb 25
Possible Torsemide side effects in 87 year old female
Reported by a physician from Japan on 2012-03-29
Patient: 87 year old female
Reactions: Poor Peripheral Circulation, LEG Amputation
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Torsemide
Administration route: Oral
Indication: Oedema
Start date: 2010-12-06
End date: 2010-12-24
Sarpogrelate
Administration route: Oral
Indication: Peripheral Arterial Occlusive Disease
Start date: 2010-11-23
Amlodipine Besylate
Administration route: Oral
Indication: Hypertension
Other drugs received by patient: Alprostadil; Dorner; Pletal
Possible Torsemide side effects in 87 year old female
Reported by a physician from Japan on 2012-03-29
Patient: 87 year old female
Reactions: Vascular Insufficiency, Drug Ineffective, Oedema, Condition Aggravated, LEG Amputation, Hypertension
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Torsemide
Dosage: 8 mg (8 mg, 1 in 1 d), oral
Administration route: Oral
Indication: Oedema
Start date: 2010-12-06
End date: 2010-12-24
Norvasc
Dosage: (7.5 mg), oral
Administration route: Oral
Indication: Hypertension
Anplag (Sarpogrelate Hydrochloride)
Dosage: (300 mg), oral
Administration route: Oral
Indication: Peripheral Arterial Occlusive Disease
Start date: 2010-11-23
Other drugs received by patient: Alprostadil; Pletal; Dorner (Beraprostsodium)
Possible Torsemide side effects in male
Reported by a physician from Germany on 2012-03-22
Patient: male, weighing 94.0 kg (206.8 pounds)
Reactions: Left Ventricular Failure, Intracardiac Thrombus, Hypertensive Crisis, Infection
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Diovan HCT
Dosage: 80 /25 mg, daily
Indication: Cardiac Failure
Start date: 2008-01-01
Procoralan
Dosage: 10 mg, daily
Administration route: Oral
Indication: Cardiac Failure
Start date: 2011-01-01
Falithrom
Dosage: 3 mg, daily
Administration route: Oral
Indication: Thrombophlebitis Superficial
Start date: 2009-01-01
Rasilez
Administration route: Oral
Indication: Hypertension
Fluvastatin Sodium
Dosage: 30 mg, daily
Administration route: Oral
Indication: Hyperlipidaemia
Start date: 2008-01-01
Torsemide
Dosage: 7.5 mg, daily
Administration route: Oral
Indication: Cardiac Failure
Start date: 2008-01-01
Glimepiride
Dosage: 4 mg , daily
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2008-01-01
Metformin HCL
Dosage: 2000 mg, daily
Start date: 2008-01-01
Diovan HCT
Dosage: 320/25 mg, daily
Bisoprolol Fumarate
Dosage: 7.5 mg, daily
Administration route: Oral
Indication: Coronary Artery Disease
Start date: 2008-01-01
Rasilez
Dosage: 150 mg, daily
End date: 2012-01-17
Diovan HCT
Dosage: 160 /25 mg, daily
Other drugs received by patient: Platelet Aggregation Inhibitors; Thienopyridine; Anticoagulants
Possible Torsemide side effects in male
Reported by a physician from Germany on 2012-03-22
Patient: male, weighing 94.0 kg (206.8 pounds)
Reactions: Intracardiac Thrombus, Left Ventricular Failure, Hypertensive Crisis, Infection
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Torsemide
Dosage: 7.5 mg, daily
Administration route: Oral
Indication: Cardiac Failure
Start date: 2008-01-01
Procoralan
Dosage: 10 mg, daily
Administration route: Oral
Indication: Cardiac Failure
Start date: 2011-01-01
Rasilez
Administration route: Oral
Indication: Hypertension
Falithrom
Dosage: 3 mg, daily
Administration route: Oral
Indication: Thrombophlebitis Superficial
Start date: 2009-01-01
Diovan HCT
Dosage: 80 /25 mg, daily
Indication: Cardiac Failure
Start date: 2008-01-01
Fluvastatin Sodium
Dosage: 30 mg, daily
Administration route: Oral
Indication: Hyperlipidaemia
Start date: 2008-01-01
Glimepiride
Dosage: 4 mg , daily
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2008-01-01
Bisoprolol Fumarate
Dosage: 7.5 mg, daily
Administration route: Oral
Indication: Coronary Artery Disease
Start date: 2008-01-01
Rasilez
Dosage: 150 mg, daily
End date: 2012-01-17
Diovan HCT
Dosage: 160 /25 mg, daily
Diovan HCT
Dosage: 320/25 mg, daily
Metformin HCL
Dosage: 2000 mg, daily
Start date: 2008-01-01
Other drugs received by patient: Platelet Aggregation Inhibitors; Thienopyridine; Anticoagulants
Possible Torsemide side effects in 87 year old female
Reported by a physician from Japan on 2012-03-19
Patient: 87 year old female
Reactions: Poor Peripheral Circulation, LEG Amputation
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Sarpogrelate
Administration route: Oral
Indication: Peripheral Arterial Occlusive Disease
Start date: 2010-11-23
Amlodipine Besylate
Administration route: Oral
Indication: Hypertension
Torsemide
Administration route: Oral
Indication: Oedema
Start date: 2010-12-06
End date: 2010-12-24
Other drugs received by patient: Dorner; Pletal; Alprostadil
Possible Torsemide side effects in male
Reported by a physician from Germany on 2012-03-14
Patient: male, weighing 94.0 kg (206.8 pounds)
Reactions: Coronary Artery Thrombosis, Left Ventricular Failure, Hypertensive Crisis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Rasilez
Administration route: Oral
Indication: Hypertension
Metformin HCL
Dosage: 2000 mg, daily
Start date: 2008-01-01
Rasilez
Dosage: 150 mg, daily
End date: 2012-01-17
Diovan HCT
Dosage: 320/25 mg, daily
Falithrom
Dosage: 3 mg, daily
Administration route: Oral
Indication: Thrombophlebitis Superficial
Start date: 2009-01-01
Fluvastatin Sodium
Dosage: 30 mg, daily
Administration route: Oral
Indication: Hyperlipidaemia
Start date: 2008-01-01
Torsemide
Dosage: 7.5 mg, daily
Administration route: Oral
Indication: Cardiac Failure
Start date: 2008-01-01
Diovan HCT
Dosage: 160 /25 mg, daily
Procoralan
Dosage: 10 mg, daily
Administration route: Oral
Indication: Cardiac Failure
Start date: 2011-01-01
Diovan HCT
Dosage: 80 /25 mg, daily
Indication: Cardiac Failure
Start date: 2008-01-01
Glimepiride
Dosage: 4 mg , daily
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2008-01-01
Bisoprolol Fumarate
Dosage: 7.5 mg, daily
Administration route: Oral
Indication: Coronary Artery Disease
Start date: 2008-01-01
Other drugs received by patient: Thienopyridine; Platelet Aggregation Inhibitors; Anticoagulants
Possible Torsemide side effects in male
Reported by a physician from Germany on 2012-03-14
Patient: male, weighing 94.0 kg (206.8 pounds)
Reactions: Coronary Artery Thrombosis, Left Ventricular Failure, Hypertensive Crisis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Rasilez
Administration route: Oral
Indication: Hypertension
Fluvastatin Sodium
Dosage: 30 mg, daily
Administration route: Oral
Indication: Hyperlipidaemia
Start date: 2008-01-01
Procoralan
Dosage: 10 mg, daily
Administration route: Oral
Indication: Cardiac Failure
Start date: 2011-01-01
Falithrom
Dosage: 3 mg, daily
Administration route: Oral
Indication: Thrombophlebitis Superficial
Start date: 2009-01-01
Diovan HCT
Dosage: 80 /25 mg, daily
Indication: Cardiac Failure
Start date: 2008-01-01
Diovan HCT
Dosage: 160 /25 mg, daily
Bisoprolol Fumarate
Dosage: 7.5 mg, daily
Administration route: Oral
Indication: Coronary Artery Disease
Start date: 2008-01-01
Rasilez
Dosage: 150 mg, daily
End date: 2012-01-17
Diovan HCT
Dosage: 320/25 mg, daily
Metformin HCL
Dosage: 2000 mg, daily
Start date: 2008-01-01
Torsemide
Dosage: 7.5 mg, daily
Administration route: Oral
Indication: Cardiac Failure
Start date: 2008-01-01
Glimepiride
Dosage: 4 mg , daily
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2008-01-01
Other drugs received by patient: Platelet Aggregation Inhibitors; Thienopyridine; Anticoagulants
Possible Torsemide side effects in 87 year old female
Reported by a physician from Japan on 2012-03-13
Patient: 87 year old female
Reactions: Intermittent Claudication, Pain, Oedema, Hypoaesthesia, LEG Amputation, Gait Disturbance, Feeling Cold
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Anplag (Sarpogrelate Hydrochloride)
Dosage: (300 m), oral
Administration route: Oral
Indication: Peripheral Arterial Occlusive Disease
Start date: 2010-11-23
Torsemide
Dosage: 8 mg (8 mg, 1 in 1 d), oral
Administration route: Oral
Indication: Oedema
Start date: 2010-12-06
End date: 2010-12-24
Norvasc
Dosage: (7.5 mg), oral
Administration route: Oral
Indication: Hypertension
Other drugs received by patient: Pletal; Dorner (Beraprost Sodium); Paulux (Alprostadil)
Possible Torsemide side effects in female
Reported by a physician from Germany on 2012-02-23
Patient: female, weighing 75.0 kg (165.0 pounds)
Reactions: Metabolic Acidosis, Urine Output Decreased, Oedema, Renal Failure Acute
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Rasilez
Dosage: 300 mg, qd
Administration route: Oral
Indication: Hypertension
End date: 2011-11-07
Torsemide
Dosage: 10 mg, per day
Administration route: Oral
Indication: Hypertension
Ramipril
Dosage: 10 mg, per day
Administration route: Oral
Indication: Hypertension
Other drugs received by patient: Tramadol HCL; Amlodipine; Novalgin; Simvastatin
Possible Torsemide side effects in male
Reported by a physician from Germany on 2012-02-08
Patient: male, weighing 90.0 kg (198.0 pounds)
Reactions: Shock Haemorrhagic, Disseminated Intravascular Coagulation, Haematoma
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Pradaxa
Indication: Cerebral Infarction
Bisoprolol
Dosage: 50 mg
Administration route: Oral
Indication: Coronary Artery Disease
Start date: 2002-01-01
Bisoprolol
Indication: Hypertension
Aspirin
Dosage: 100 mg
Administration route: Oral
Indication: Coronary Artery Disease
Start date: 2002-01-01
End date: 2012-01-22
Ramipril
Dosage: 10 mg
Administration route: Oral
Indication: Hypertension
Start date: 2002-01-01
Pradaxa
Dosage: 220 mg
Administration route: Oral
Indication: Atrial Fibrillation
Start date: 2011-10-19
End date: 2012-01-22
Aspirin
Indication: Myocardial Infarction
Bayotensin
Dosage: 20 mg
Administration route: Oral
Indication: Coronary Artery Disease
End date: 2012-01-22
Simvastatin
Dosage: 40 mg
Administration route: Oral
Indication: Hyperlipidaemia
End date: 2012-01-22
Bayotensin
Indication: Hypertension
Torsemide
Dosage: 5 mg
Administration route: Oral
Indication: Hypertension
End date: 2012-01-22
Aspirin
Indication: Coronary Artery Bypass
Page 1 Next >>
|